Article

Eyetracking system approved

The FDA has given Bausch & Lomb approval to market its Active EyetrackingSystem in the United States.

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Related Content
BLINK2 study confirms lasting myopia control benefits in teenagers
January 22nd 2025

BLINK2 study confirms lasting myopia control benefits in teenagers

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

HelpMeSee announces new training partnerships, simulation training sites
January 21st 2025

HelpMeSee announces new training partnerships, simulation training sites

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Rayner launches redesign of IOL calculator RayTrace
January 20th 2025

Rayner launches redesign of IOL calculator RayTrace

InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
January 19th 2025

InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company

© 2025 MJH Life Sciences

All rights reserved.